Oxford Immunotec Global 10-Q2019 Q1 Quarterly report

Filed: 9 May 19, 4:09pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: aim, aimed, area, arrangement, commencement, commencing, Committee, compelled, component, constituting, Consumer, departure, depository, Description, document, earned, environment, estate, evolve, expansion, expedient, extension, extinguishment, facilitate, factually, fixed, forma, gain, governmental, greater, higher, highly, illustrative, immunology, implicit, incremental, index, land, lapse, leading, leveraging, liquid, made, Marlborough, mentioned, model, Patent, pro, quality, readily, reassessed, remediated, remediation, Remuneration, renew, renewal, repurposed, reset, settle, settled, seventeen, spend, split, Stability, sufficient, tiered, transparency, TSA, twelve, typically, underlying, unwilling, warehousing, withdrawal, workflow, worldwide

Removed: accounted, accredited, acute, adding, adjacent, Administration, Affordable, American, apply, assist, assurance, asymptomatic, attractive, autoimmune, awarded, Babesia, bifurcate, bite, calling, CAP, categorize, CE, cell, cellular, certified, chain, characterized, chronic, clarification, cleared, CLIA, CMV, code, collective, College, committed, communicated, copy, CPT, delay, depict, diversity, Drug, electronically, eligible, ELISATM, emerging, equity, escalating, evaluate, exemption, expensive, explain, fatal, FDA, final, Food, France, growing, highest, historically, immune, Improvement, industry, infected, inflammatory, inform, informing, inherently, inspect, intention, International, introduction, involving, irrevocably, Jersey, Jumpstart, large, larger, Lastly, LDT, left, licensure, Lyme, making, mark, marked, marker, mature, microti, molecular, monitor, monitoring, monthly, objective, obtained, offered, opportunity, owner, parasite, patient, peptide, pivotal, pledged, PMA, polymerase, PPACA, practice, premarket, prevalent, private, Procedural, processed, progression, promised, prosecute, Protection, pursue, quantitative, ranging, rare, reaction, reduced, referred, registered, reimbursed, rejection, relating, rentable, rental, require, requiring, response, responsible, retrospectively, revised, rollforward, room, Scope, seek, spectrum, State, Street, strength, submit, Switzerland, technical, Tennessee, Terminology, tick, trademark, transfusion, transmitted, transplant, transplantation, treatment, uncertain, uncertainty, underserved, University, unrecognised, untreated, utilizing, variation, Washington, weighted, wide, widely

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated Oxford Immunotec Global transcripts

Oxford Immunotec Global similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Oxford Immunotec Global PLC, a company incorporated in England and Wales (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended March 31, 2019 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2019	/s/ Peter Wrighton-Smith, Ph.D.
	Peter Wrighton-Smith, Ph.D. Chief Executive Officer and Director

Date: May 9, 2019	/s/ Matthew T E McLaughlin
	Matthew T E McLaughlin Chief Financial Officer

This certification is being furnished and not filed, and shall not be incorporated into any document for any purpose, under the Securities Exchange Act of 1934 or the Securities Act of 1933.